ALGORITHM OF ASSESSMENT OF ASTHMA CONTROL
- Authors: Nazarova EV1, Kurbacheva O.M.1, Il'ina NI1, Nazarova EV2, Kurbacheva OM2, Ilina NI2
-
Affiliations:
- ФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. Москва
- Institute of immunology, Moscow, Russia
- Issue: Vol 8, No 2 (2011)
- Pages: 27-33
- Section: Articles
- URL: https://journals.rcsi.science/raj/article/view/121127
- DOI: https://doi.org/10.36691/RJA780
- ID: 121127
Cite item
Open Access
Access granted
Subscription Access
Abstract
Background. To study informativeness, clinical significance and relationship between objective and subjective methods of assessing asthma control and creation an optimal algorithm.
Methods. The study involved 40 patients of both sex, aged from 18 to 75 years old suffering from persistent, moderate and severe asthma , having no control.
Results. All patients were assessed asthma control using methods based on subjective data (medical history, filling the questionnaires: the ACT and AQLQ; survey on the presence of comorbidity) and objective methods of examination (auscultation, PEV, spirometry, ECP in blood, content of eosinophils in induced sputum and peripheral blood). All patients were assigned to anti-asthma therapy combination therapy (ICS+LABA). The main reasons for lack of asthma control is the inadequacy of basic therapy and concomitant diseases. Symptoms and normalization of ERF occur much earlier (on day 30 of therapy) than the relief of bronchial inflammation. Adequate methods to assess asthma control are objective methods, subjective can only be used as an extra.
Conclusion. The analysis of the causes of asthma control in each individual case, increased medical supervision over appointments and continuous monitoring by means of subjective and objective ways of assessing control, avoid excessive use of pharmaceutical loads, to minimize the side effects of treatment, faster to achieve better results by optimizing costs treatment.
Methods. The study involved 40 patients of both sex, aged from 18 to 75 years old suffering from persistent, moderate and severe asthma , having no control.
Results. All patients were assessed asthma control using methods based on subjective data (medical history, filling the questionnaires: the ACT and AQLQ; survey on the presence of comorbidity) and objective methods of examination (auscultation, PEV, spirometry, ECP in blood, content of eosinophils in induced sputum and peripheral blood). All patients were assigned to anti-asthma therapy combination therapy (ICS+LABA). The main reasons for lack of asthma control is the inadequacy of basic therapy and concomitant diseases. Symptoms and normalization of ERF occur much earlier (on day 30 of therapy) than the relief of bronchial inflammation. Adequate methods to assess asthma control are objective methods, subjective can only be used as an extra.
Conclusion. The analysis of the causes of asthma control in each individual case, increased medical supervision over appointments and continuous monitoring by means of subjective and objective ways of assessing control, avoid excessive use of pharmaceutical loads, to minimize the side effects of treatment, faster to achieve better results by optimizing costs treatment.
About the authors
E V Nazarova
ФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. МоскваФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. Москва
Oksana Mikhaylovna Kurbacheva
ФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. Москва
Email: kurbacheva@gmail.ru <mailto:kurbacheva@gmail.ru>
ФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. Москва
N I Il'ina
ФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. МоскваФГБУ «ГНЦ Институт иммунологии» ФМБА России, г. Москва
E V Nazarova
Institute of immunology, Moscow, RussiaInstitute of immunology, Moscow, Russia
O M Kurbacheva
Institute of immunology, Moscow, RussiaInstitute of immunology, Moscow, Russia
N I Ilina
Institute of immunology, Moscow, RussiaInstitute of immunology, Moscow, Russia
References
- Kheradmand F., Rishi K., Corry D.B. Environmental contributions to the allergic asthma epidemic. Environ Health Perspect. 2002, v. 110 (Suppl. 4), р. 553-56.
- World Health Organization. Fact sheet 206. Bronchial asthma. (Accessed October 24, 2005), р. 57-63.
- Eagan T.M., Brogger J.C., Eide G.E., Bakke P.S. The incidence of adult asthma: a review. Int. J. Tuberc. Lung. Dis. 2005, Jun, 9 (6), р. 603-612.
- Masoli M., Fabian D., Holt S., Beasley R. Global burden of asthma. 2004, р. 56-79.
- Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 2004, v. 59, р. 469-78
- Федосеев Г.Б., Трофимов В.И. Бронхиальная астма. СПб., 2006, с. 30-56.
- GINA. The Global Burden of Asthma Report. 2006, р. 21-88.
- Смирнов Н.А., Смоленов И.В. БА в Центральной и Восточной Европе: представления больных и реальная клиническая практика (результаты исследования AJR-CEE). Аллергология. 2001, № 4, с. 3-9.
- Чучалин А.Г., Белевский А.С., Смоленов И.В. и соавт. Факторы, влияющие на качество жизни больных с бронхиальной астмой. Пульмонология. 2004, № 1, с. 69-83.
- Вылегжанина Т.Г., Ильина Н.И. Беклазон Эко Легкое Дыхание - «золотой стандарт» базисной терапии бронхиальной астмы. Пульмонология. Приложение. 2006, с. 23-27.
- Wallenstein G.V., Carranza-Rosenzweig J., Kosinski M., Blaisdell-Gross B., Gajria K., Jhingran P. A psychometric comparison of three patient-based measures of asthma control. Curr. Med. Res. Opin. 2007, 23, р. 369-377.
- Humbert M., Holgate S., Boulet L.P., Bousquet J. Asthma control or severity: that is the question. Allergy. 2007, 62, р. 95-101.
- Jones P.W. Breathlessness perception in airways obstruction. Eur. Respir. J. 1992, 5, р. 1035-1036.
- Bateman E.D., Bousquet J., Braunstein G.L. Is overall asthma control being achieved? A hypothesis-generating study. Eur. Respir. J. 2001, v. 17, p. 589-595.
- Leblanc A., Robichaud P., Lacasse Y., Boulet L.P. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy. 2007, 62, р. 120-125.
- Foresi A., Morelli M.C., Catena E. on behalf of the Italian Study Group. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest. 2000, 117, р. 440-446.
- Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999; the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. 2000, 16, р. 802-807.
- Wenzel S.E., Szefler S.J., Leung D.Y. et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high-dose glucocorticoids. Аm. J. Respir. Crit. Саrе Med. 1997, 156, p. 737-743.
- Lonnkvist K., Hellman C., Lundahl J., Hallden G., Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J. Allergy Clin. Immunol. 2001, 107, p. 812-817.
- Jayaram L., Pizzichini M.M., Cook R.J et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur. Respir. J. 2006, 27, р. 483-494.
- Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P. et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002, 360, р. 1715-1721.
Supplementary files
